Therapeutic effects of hydrogen on chronic graft-versus-host disease.
Liren Qian, Xiaopeng Liu, Jianliang Shen, Defeng Zhao, Wenjie Yin · Journal of cellular and molecular medicine · 2017
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In mice, figure 1 Administration of hydrogen‐rich saline intraperitoneally from the 20th day after transplantation protects mice from cGVHD ( n = 30, P < 0.05). These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in mice. Figure 1 Administration of hydrogen‐rich saline intraperitoneally from the 20th day after transplantation protects mice from cGVHD ( n = 30, P < 0.05).
What the Researchers Studied
The researchers studied mice. The study used a preclinical animal experiment.
What Effects Did Molecular Hydrogen Have?
As the researchers previously reported 18, 19, 20, hydrogen was dissolved in physiological saline 6 hrs under high pressure (0.4 MPa) to a supersaturated level using hydrogen‐rich water producing apparatus produced by the authors' department. The saturated hydrogen saline was stored under atmospheric pressure at 4°C in an aluminium bag with no dead volume. Hydrogen‐rich saline was freshly prepared every week, which ensured that a concentration of more than 0.6 mM was maintained. Figure 1 Administration of hydrogen‐rich saline intraperitoneally from the 20th day after transplantation protects mice from cGVHD ( n = 30, P < 0.05). Recent studies showed that molecular hydrogen has anti-inflammatory, antioxidant, anti-fibrosis effects. The mechanism may rely on the anti‐inflammatory, antioxidant and anti‐fibrosis ability of hydrogen.
Why These Findings Matter
These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.
How Strong Is This Evidence?
This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.
Technical Study Details
H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was mice. The study used a preclinical animal experiment.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.